Aurora Cannabis Inc (NYSE:ACB) Q4 2020 Earnings Conference Call - Final Transcript

Sep 22, 2020 • 05:00 pm ET


Aurora Cannabis Inc (NYSE:ACB) Q4 2020 Earnings Conference Call - Final Transcript


Loading Event

Loading Transcript


Good afternoon, everyone and welcome to the Aurora Cannabis Fourth Quarter Fiscal 2020 Conference Call for the Three Months Ending June 30, 2020. This is being recorded today, Tuesday, September 22nd, 2020.

Listeners are reminded that certain matters discussed in today's conference call or answers that may be given to questions asked could constitute forward-looking statements that are subject to the risks and uncertainties relating to the Aurora's future financial or business performance. Actual results could differ materially from those anticipated in these forward-looking statements. The risk factors that may affect results are detailed in Aurora's annual information form and other periodic filings and registration statements. The company expects to file these documents before the end of this week and they may be accessed via the SEDAR or EDGAR databases.

Since we are conducting today's call from a respective remote location, there may be brief delays, cross-talk or other minor technical issues during this call. We thank you in advance for your patience and understanding.

I would now like to introduce Mr. Miguel Martin, Chief Executive Officer for Aurora Cannabis. Please go ahead, Mr. Martin.

Miguel Martin

Thank you, operator, and good afternoon, everyone, and thank you for giving us your time. First off, let me say that very much appreciate the Board's confidence in appointing me to the CEO role. I'm pleased to be working with the team on tactical plans to establish Aurora as a profitable growth-oriented leader in the global cannabinoid market. I take my fiduciary responsibilities to our investors very seriously and are determined to do everything that I can to enhance shareholder value. This begins with managing the business for the high degree of fiscal discipline, especially in the midst of a global pandemic.

Over the last several days, I've had an opportunity to speak to a few of you in the investment community. But for the broader audience, perhaps it would be helpful to provide a bit of my background. I've spent my entire career in sales, marketing and leadership roles within the regulated CPG product industry. I started my career with Altria and spent about 18 years there, ultimately leading their sales group. I then went to become the President of one of the largest electronic cigarette companies Logic which was then sold to Japan Tobacco, the third largest tobacco company in the world. After that, I went to a startup and became CEO of Eleva CBD, currently ranked the number one CBD company in Nielsen which was just recently acquired by Aurora. So I spent a lot of time working in fast pace, constantly evolving, highly regulated and fluid environments where adherence to compliance and testing is essential to success.

I accepted the CEO job because I see an opportunity to quickly leverage my skill-set in a regulated CBG product development here at Aurora. I'm fortunate to step into a company built with a dedication to science and a compliance-first approach. With strong execution, I expect to build a profitable business in Canada that we